On April 29th, 2014, the Chemistry laboratories at WMH and BGH will be transitioning to new Chemistry equipment, the Roche Cobas 6000. As part of this instrumentation change, the laboratory will be making several changes to the in-house Urine Drug Screen testing it offers. The changes are outlined below:
•Two Urine Drug Screens will be available in-house:
Urine Drug Screen
Urine Drug Screen (with Methadone)
•The basic testing offered in these screens will be: Alcohol, Amphetamine, Barbituates, Benzodiazepines, Cannabis, Cocaine, Opiates, Creatinine, and Methadone (if indicated)
•For the Benzodiazepine assay, the screening cut-off will be lowered from 200 ng/mL to 100 ng/mL
•The Opiate assay will not detect Oxycodone and its Metabolites
Please note that all urine drug screen results are screening results only. Any “positive” results which exceed the cut-off values of the assays are not confirmed by independent methods and should be used for medical/treatment purposes only. Any confirmatory testing required, or any testing required for assays not performed in-house can be performed at our reference laboratory, provided the appropriate specimen(s) and order(s) are submitted to the laboratory. Please be aware that any urine drug testing sent to our reference laboratory may have a turn-around time of up to a week.
Should there be any questions, please contact the WMH Chemistry Supervisor, Angela K. Armato, at 763-5780, the BGH Laboratory Supervisor, Rosie Parkinson, at 762-2366. Thank you.